SCHEMBL369952

SCHEMBL369952

Cc1cc(Cl)ccc1C(CC(=NO)c1ccc(=O)n(C)c1)c1ccc(NS(C)(=O)=O)cc1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 5/20 0.37
BRD4 O60885 2/20 0.35
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
GPR27 Q9NS67 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
KCNH2 Q12809 1/20 0.33
CPT2 P23786 1/20 0.33
CPT1A P50416 1/20 0.33
KIF11 P52732 1/20 0.32
P2RX3 P56373 1/20 0.32
CREBBP Q92793 1/20 0.32
IDH1 O75874 1/20 0.32
KAT2B Q92831 1/20 0.31
HPGD P15428 1/20 0.31
RECQL P46063 1/20 0.31
EGFR P00533 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1389707 1.00 GPBAR1 (0.37) GPBAR1BRD4KDM4ELMNAGPR27
SCHEMBL10241385 0.97 GPBAR1 (0.39) GPBAR1BRD4KDM4ELMNAGPR27
SCHEMBL1390497 0.97 GPBAR1 (0.39) GPBAR1BRD4KDM4ELMNAGPR27
SCHEMBL1390498 0.97 GPBAR1 (0.39) GPBAR1BRD4KDM4ELMNAGPR27
SCHEMBL1390208 0.90 BRPF1 (0.36) GPBAR1GPR27CREBBPIDH1
SCHEMBL1390555 0.89 KDM4E (0.38) BRD4KDM4ELMNAGPR27SLC6A2
SCHEMBL368808 0.89 GPBAR1 (0.41) GPBAR1BRD4EGFR
SCHEMBL1389674 0.89 GPBAR1 (0.41) GPBAR1BRD4EGFR
SCHEMBL368806 0.89 GPBAR1 (0.41) GPBAR1BRD4EGFR
SCHEMBL1389671 0.89 GPBAR1 (0.41) GPBAR1BRD4EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP claimed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885BRD4 3540/4885KDM4E 4298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.